Done sou Salè H1B

Akèy › Metiyè › Regulatory Affairs Managers

Regulatory Affairs Managers: Salè H-1B

Klasifikasyon Okipasyonèl Estanda 11-9199. 2,134 aplikasyon kondisyon travay; salè baz medyàn ofri $154,500, mwatye mitan $120,786–$191,166.

Demann (LCA)2,134
Salè medyan ofri$154,500
Mwatye salè yo$120,786–$191,166
10yèm–90yèm pousantaj$98,509–$229,800

Pa nivo salè

Nivo revniLCASalè medyan
Nivo I (antre)336$104,957
Nivo II (kalifye)608$138,840
Nivo III (eksperyans)422$176,010
Nivo IV (plen kompetans)478$211,850

Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.

Anplwayè yo

AnplwayèLCASalè medyan
Takeda Development Center Americas, Inc.44$185,065
Google LLC36$161,000
Meta Platforms, Inc28$191,560
Amgen Inc.24$148,356
Amazon.com Services LLC20$152,147
Sanofi US Services Inc.18$133,026
AstraZeneca Pharmaceuticals LP17$181,709
Gilead Sciences, Inc.17$165,192
ByteDance Inc.17$217,000
Freyr,Inc.15$115,710
NextDecade LNG LLC15$185,000
Intuit Inc.14$187,382
TikTok Inc.13$257,600
Rising Pharma Holdings Inc.12$140,122
McKinsey & Company, Inc. United States12$230,300
Wal-Mart Associates, Inc.12$139,910
Novavax, Inc.12$162,000
Edwards Lifesciences LLC12$167,586
Morgan Stanley Services Group Inc.11$183,000
Uber Technologies, Inc.11$167,500
BeiGene USA, Inc.10$183,500
Becton, Dickinson and Company10$170,000
AbbVie Inc.9$170,000
Regeneron Pharmaceuticals, Inc.9$175,004
Apellis Pharmaceuticals Inc.9$148,384
TT Commerce & Global Services LLC9$185,892
Sage Therapeutics, Inc.8$172,977
Intuitive Surgical Operations, Inc.8$154,892
Teva Pharmaceuticals USA, Inc.8$140,844
eClinicalWorks LLC8$167,000
D. E. Shaw & Co., L.P.8$162,500
ModernaTX, Inc.8$195,458
Belcher Pharmaceuticals, LLC8$111,322
Incyte Corporation8$181,938
The Veritas Healthcare Solutions LLC7$115,918
Kpmg LLP7$114,500
Bristol-Myers Squibb Company7$145,100
Parexel International LLC7$122,000
PPD Development, L.P.6$118,114
Blueprint Medicines Corporation6$152,286
Bloomberg L.P.6$142,418
Karyopharm Therapeutics Inc.6$179,250
Penumbra, Inc.6$222,602
Alexion Pharmaceuticals, Inc.6$157,630
St. Jude Medical, Cardiology Division, Inc.6$134,769
Moderna Services, Inc.6$195,000
Sanofi Pasteur Inc.6$108,078
Block, Inc.6$184,500
Riconpharma, LLC6$136,912
Sun Pharmaceutical Industries, Inc.5$210,000

Vil yo

Tit travay

Pa ane fiskal

Ane fiskalLCASalè medyan
FY2023575$149,157
FY2024617$150,000
FY2025583$156,140
FY2026359$171,621

Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).